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Abstract
Background: Supramalleolar osteotomy (SMO) is reported to be an effective treatment for varus ankle osteoarthritis
by redistributing the load line within the ankle joint. Mesenchymal stem cells (MSCs) have been proposed as a new
treatment option for osteoarthritis on the basis of their cartilage regeneration ability. The purpose of this study was
to compare the clinical, radiological, and second-look arthroscopic outcomes between MSC injection with marrow
stimulation and marrow stimulation alone in patients with varus ankle osteoarthritis who have undergone SMO.
Methods: In this retrospective study, 62 patients (64 ankles) with varus ankle osteoarthritis underwent second-look
arthroscopy at a mean of 12.8 months after arthroscopic marrow stimulation combined with SMO; 33 ankles were
subjected to marrow stimulation alone (group I), and 31 were subjected to marrow stimulation with MSC injection
(group II). Clinical outcome measures included a visual analog scale (VAS) for pain and the American Orthopaedic
Foot and Ankle Society (AOFAS) score. Radiological outcome variables included the tibial–ankle surface (TAS), talar
tilt (TT), and tibial–lateral surface (TLS) angles. In second-look arthroscopy, cartilage regeneration was evaluated
using the International Cartilage Repair Society (ICRS) grade.
Results: The mean VAS score improved significantly from 7.2 ± 1.0 to 4.7 ± 1.4 in group I and from 7.3 ± 0.8
to 3.7 ± 1.5 in group II at the final follow-up (P < 0.001 for both groups). The mean AOFAS score also
improved significantly from 61.7 ± 5.8 to 80.9 ± 6.7 in group I and from 60.6 ± 6.1 to 85.2 ± 5.1 in group II
at the final follow-up (P < 0.001 for both groups). There were significant differences in the mean VAS and
AOFAS scores between groups at the final follow-up (P = 0.002 and 0.010, respectively). At second-look
arthroscopy, there were significant differences in ICRS grades between groups(P = 0.015 for medial aspect of
the talar dome, P = 0.044 for medial aspect of the tibial plafond, and P = 0.005 for articular surface of the
medial malleolus). ICRS grades were significantly correlated with clinical outcomes in both groups (all P < 0.05). Mean
TAS, TT, and TLS angles improved significantly after SMO in both groups but were not significantly correlated with
clinical outcomes or ICRS grade (all n.s.).
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Conclusions: The clinical and second-look arthroscopic outcomes of MSC injection with marrow stimulation were
better compared to those of marrow stimulation alone in patients with varus ankle osteoarthritis who have undergone
SMO. Furthermore, the ICRS grade is significantly correlated with clinical outcome.
Keywords: Mesenchymal stem cell, Marrow stimulation, Supramalleolar osteotomy, Varus ankle osteoarthritis
Background
Supramalleolar osteotomy (SMO) has been reported to
successfully restore normal joint function or halt further
disease progression in varus ankle osteoarthritis (Cheng
et al. 2001; Kim et al. 2014b; Pagenstert et al. 2007; Tanaka
et al. 2006). SMO aims to alter the joint mechanics in a
varus ankle by correcting the medial displacement of the
load line and shifting the medial concentration of the
stress laterally onto the intact articular cartilage of the
lateral side within the ankle (Becker and Myerson 2009;
Castagnini et al. 2016; Cheng et al. 2001). However, al-
though SMO can alter the weight-bearing axis, which
provides an ideal mechanical environment for halting
degenerative changes in the articular cartilage, the overall
long-term success of SMO remains debatable if cartilage re-
generation of medial osteoarthritic lesions is not achieved.
Although cartilage regenerative procedures such as
marrow stimulation are not traditional treatment mea-
sures for osteoarthritis, they are gaining increasing interest
because of their potential to provide pain relief and alter
osteoarthritis progression (Lyu et al. 2012; Zhu et al.
2013). Therefore, a marrow stimulation procedure for
arthritic lesions in the medial aspect of the ankle joint
may improve the overall outcomes of SMO in varus ankle
osteoarthritis. Kim et al (Kim et al. 2014b) performed
arthroscopic marrow stimulation along with SMO in pa-
tients with varus ankle osteoarthritis and assessed cartilage
regeneration after arthroscopic marrow stimulation using
second-look arthroscopic evaluation; the cartilage regener-
ation of medial osteoarthritic lesions was significantly as-
sociated with the clinical outcomes of SMO. Therefore,
they concluded that arthroscopic marrow stimulation
should be considered with SMO to ensure adequate
cartilage regeneration of the medial aspect of the ankle
joint. Marrow stimulation treatment primarily aims to
recruit mesenchymal stem cells (MSCs) from bone marrow,
which leads to coverage of the lesion with fibrous cartilage
(Giannini et al. 2009; Hangody et al. 2001; Kono et al.
2006). This treatment provides acceptable clinical results
over midterm follow-up periods but often fail in the long
term because of biomechanical insufficiency of the re-
generative fibrous cartilage and scar tissue that results
from this method (Baltzer and Arnold 2005). Recently,
MSCs have been suggested for use in the cell based
treatment of cartilage lesions. Regarding in vitro stud-
ies, the application of MSCs into full-thickness articular
cartilage defects has been attempted under various con-
ditions, and MSCs have been used with success in hy-
brid scaffolds to repair cartilage lesions in animal
models (Han et al. 2008; Kobayashi et al. 2008). More-
over, MSCs were recently proposed as a new treatment
option for osteoarthritis on the basis of their ability to
differentiate into chondrocytes as well as the paracrine
effects of their secreted bioactive materials (Barry and
Murphy 2013; Beris et al. 2005; Caplan and Dennis
2006; Galois et al. 2005; Oreffo et al. 2005).
We hypothesized that the additional injection of MSCs
would improve the outcomes of marrow stimulation in
patients with varus ankle osteoarthritis who have under-
gone SMO, because of their capability to differentiate
into articular cartilage as a result of injection into cartil-
age lesions. The purpose of this study was to compare
the clinical, radiological, and second-look arthroscopic
outcomes between MSC injection with marrow stimula-
tion and marrow stimulation alone in patients with varus
ankle osteoarthritis who have undergone SMO.
Methods
Patient enrollment
This retrospective comparative study was designed to
evaluate the effectiveness of MSC injection in patients
who underwent marrow stimulation with SMO for varus
ankle osteoarthritis. The study protocol was approved by
our institutional review board, andwritten informed con-
sentwas obtained from all study participants. In this
study, the indication for SMO was stage 2 or 3A osteo-
arthritis according to the Takakura classification system
as modified by Tanaka et al. (Tanaka et al. 2006). Patients
with a history of surgical treatments or arthritic changes in
the entire ankle joint, deformity proximal to the ankle as
seen on plain radiographs, or varus deformity of the hind
foot as seen in the heel alignment view were excluded.
From May 2009 to September 2013, 90 consecutive pa-
tients including 96 ankles with medial ankle osteoarthritis
and varus deformity underwent SMO with arthroscopic
marrow stimulation. Among 90 patients, 9 patients were
excluded and 81 patients were enrolled in this study.
Patients were informed about MSCs preoperatively and
decided whether to receive them at the time of surgery;
the decision was solely up to the patients. Moreover,
before surgery, we recommended second-look arthros-
copy to all patients and explained that its purpose was
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to evaluate the medial arthritic lesion and that this
would require additional arthroscopic procedures such
as debridement, synovectomy, and adhesiolysis. Among
the 81 patients (85 ankles), second-look arthroscopy was
performed at a mean of 12.8 months postoperatively
(range, 9 to 16 months) in 64 of the 85 ankles; these 64
ankles in 62 patients were ultimately included in the
present study. Among these 64 ankles, 33 underwent
arthroscopic marrow stimulation alone (group I), and 31
underwent arthroscopic marrow stimulation with MSCs
injection (group II) (Fig. 1).
Tissue collection and isolation of cells
Subcutaneous adipose tissue was harvested from both
buttocks of each patient. One day before arthroscopic
surgery, adipose tissue was harvested by tumescent
liposuction while the patient under local anesthesia
(Klein 1996). We aimed to routinely collect 140 cc lipo-
suctioned adipose tissue: 120 cc was used for the injec-
tion, and the remaining 20 cc was analyzed to examine
the plastic-adherent cells that form fibroblast colony-
forming units (CFU-F) and confirm the multilineage
differentiation of adipose-derived stem cells.
In the operating room, 120 cc adipose tissue was sus-
pended in phosphate-buffered saline, placed in a sterile
box, and transported to the laboratory. Mature adipo-
cytes and connective tissues were separated from the
stromal vascular fraction by centrifugation as described
by Zuk et al. (Zuk et al. 2001). The remaining 20 cc adi-
pose tissue was processed in the same manner and used
for cell analysis.
Epitope profile and differentiation assay
To evaluate the frequency of mesenchymal-like progeni-
tors in the stromal vascular fraction, cells were cultured
in T-25 flasks at a final concentration of 16 cells/cm2.
Colonies consisting of ≥50-cell aggregates were scored
under an optical microscope, and the immunophenotype
of the adipose-derived stem cells was analyzed by flow
cytometry (i.e., FACS) analysis. MSC marker phenotyping
was performed using CD14, CD34, CD90, and CD105 anti-
bodies as described previously (Marchal et al. 2012). CD14
and CD34 are hematopoietic cell markers, and CD90 and
CD105 are mesenchymal cell markers. Adipose-derived
stem cells were plated at cells/cm2 in Dulbecco’s modified
Eagle medium containing 10 % fetal bovine serum and
were allowed to adhere for 24 h. The culture medium
was subsequently replaced with specific inductive media
to determine the adipogenic, osteogenic, and chondro-
genic differentiation potential as described previously
(Marchal et al. 2012).
Surgical procedures and MSC application
The patient was placed in the supine position under
spinal anesthesia. A thigh tourniquet was used for
hemostasis. Non-invasive ankle distraction (15 pounds)
Fig. 1 Flow diagram of patient involvement in the study
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was applied using an ankle harness. An anteromedial
portal adjacent to the anterior tibial tendon and an an-
terolateral portal adjacent to the peroneus tertius tendon
were used. A 2.7-mm arthroscope with a 30° angle was
used for arthroscopic evaluation. In all cases, the arth-
ritic lesions of the articular surface of the medial malle-
olus, medial aspect of the tibial plafond and/or medial
aspect of the talar dome were noted during the arthro-
scopic procedures. The arthroscopic marrow stimulation
procedure for these arthritic lesions was performed in a
standardized manner by a single surgeon (Y.S.K.). After
thorough debridement of all unstable and damaged cartil-
age in the lesion, a microfracture or abrasion arthroplasty
was performed. For the microfracture, multiple perfora-
tions perpendicular to the joint surface were made using a
2.5-mm 90° microfracture awl (Linvatec, Largo, FL, USA)
as described by Steadman et al. (Steadman et al. 2001).
For areas showing a loss of subchondral bone, abrasion
arthroplasty was performed by removing loose or osteo-
chondral fragments with a ring-shaped or curved curette
and by trimming damaged cartilage with a power shaver
until a stable and smooth articular surface was achieved.
The tourniquet was subsequently released, and adequate
bone bleeding at the microfracture holes or abrasion
arthroplasty site was confirmed. For group 2, MSCs iso-
lated 1 day preoperatively were injected after the extrac-
tion of arthroscopic fluid within the joint (Fig. 2).
After the arthroscopic procedure, SMO was performed
as follows. After the level of the osteotomy was deter-
mined by using an image intensifier, a skin incision was
made on the medial side of the distal tibia centered over
the osteotomy site. Periosteal stripping was performed,
and a Kirschner wire was placed proximal to the tip of
the medial malleolus to identify the osteotomy plane; it
was inserted obliquely toward the proximal margin of
the syndesmosis. The osteotomy was made using a broad
oscillating saw to preserve the opposite cortex, acting as
a fulcrum for the opening wedge and enhancing stability.
The deformity was carefully corrected by the stepwise
insertion of 2 or 3 osteotomes to avoid far cortex frac-
tures. Alignment was assessed using an image intensifier,
and the appropriate size of the opening wedge was deter-
mined on the basis of the preoperatively planned correc-
tion. Although, the normal values of the tibial–ankle
surface (TAS) angle and the correction angle are debated,
(Knupp et al. 2011; Lee et al. 2011; Tanaka 2012) Sugimoto
et al. (Sugimoto et al. 1997) report that the mean TAS and
tibial–lateral surface (TLS) angles in healthy Japanese
people are 88° and 81°, respectively; therefore, we attempted
to achieve these angles in the present study. The osteotomy
was subsequently stabilized using 2 single-opening
wedge plates and screws (B. Braun Aesculap, Tuttlingen,
Germany), and the osteotomy gap was filled with can-
cellous bone allograft. Postoperatively, a short leg splint
was applied for 2 weeks. Following suture removal, a
non-weight-bearing short leg cast was applied for
4 weeks. Active and passive ankle range of motion exer-
cises were initiated 6 weeks postoperatively. Sports and
high-impact activities were limited for at least 3 months
postoperatively.
Fig. 2 a–d Arthroscopic views of left ankle in a 54-year-old male patient who underwent marrow stimulation alone combined with supramalleolar
osteotomy. e–h Arthroscopic views of the left ankle in a 52-year-old female patient who underwent mesenchymal stem cell injection and marrow
stimulation combined with supramalleolar osteotomy. a, e Intraoperative arthroscopic findings showing a cartilage lesion with osteoarthritic change in
the medial gutter area. b, f Arthroscopic views showing the perforation of the subchondral bone with a microfracture awl after the debridement of all
unstable and damaged cartilage in the lesion. c, g Adequate bone bleeding at microfracture holes was confirmed after the tourniquet was released.
d Second-look arthroscopy showing poor cartilage regeneration at the microfractured site (International Cartilage Repair Society [ICRS] grade IV).
g Arthroscopic view after mesenchymal stem cell injection. h Second-look arthroscopy showing nearly normal coverage of the cartilage
lesion (ICRS grade II)
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Outcome assessments
All patients were clinically evaluated preoperatively and
during follow-up. A visual analog scale (VAS) pain score
and the American Orthopaedic Foot and Ankle Society
(AOFAS) ankle-hind foot score were used for clinical
evaluations.
Weight-bearing anteroposterior and lateral radiographs
were obtained for radiological evaluation preoperatively
and during follow-up. On the weight-bearing anteropos-
terior radiograph, the TAS angle was defined as the angle
between the tibial axis and the tibial plafond, and the talar
tilt (TT) angle was defined as the angle between the tibial
plafond and the talar dome (Fig. 3) (Kim et al. 2014b). On
the weight-bearing lateral radiograph, the TLS angle was
defined as the angle between the axis of the tibia and a line
drawn between the anterior and posterior margins of the
tibial plafond to mark the articular surface of the distal as-
pect of the tibia (Fig. 3) (Kim et al. 2014b). To avoid po-
tential bias, an independent observer, who was a trained
musculoskeletal radiologist uninvolved in patient care and
unaware of the study objectives, evaluated the radiographs.
At serial follow-up examinations, the osteotomy sites were
examined by plain radiography.
Second-look arthroscopic evaluation
The plates and screws were removed after radiological
and clinical confirmation of the union of the osteotomy
site. All second-look arthroscopies were performed by a
single surgeon (Y.S.K.) when the plates and screws that
fixed the open wedge osteotomy sites were removed.
Cartilage lesions were macroscopically evaluated after
arthroscopic marrow simulation according to the Inter-
national Cartilage Repair Society (ICRS) (Brittberg and
Peterson 1998; Peterson et al. 2000) grade. To evaluate
the cartilage lesions according to location, we divided
the cartilage lesions into 3 areas on the medial aspect of
the ankle joint: arthritic lesions of the medial aspect of
the talar dome, medial aspect of tibial plafond, and ar-
ticular surface of the medial malleolus. The ICRS grad-
ing system involves 3 criteria: the degree to which a
defect is filled by repair tissue, degree of integration of
the repair tissue with the adjacent articular cartilage, and
macroscopic appearance of the surface of the repair site.
These arthroscopic evaluation criteria were subjectively
scored from 0 to 4; they were then combined for an
overall grade from I to IV, which correspond to normal,
nearly normal, abnormal, and severely abnormal, respect-
ively (Table 1). The ICRS grading system is reported to be a
reliable and relevant means of macroscopically evaluating
cartilage regeneration after microfracture or autologous
chondrocyte implantation (van den Borne et al. 2007). Add-
itional arthroscopic procedures such as synovectomy, adhe-
siolysis, and debridement of the impinged soft tissue were
performed if pathologic lesions were found in the ankle
joint during the second-look arthroscopy.
Statistical analysis
The sample size was 64 and descriptive statistics were
presented as mean ± standard deviation (SD). The prin-
cipal dependent variables were VAS and AOFAS scores
at the final follow-up as clinical outcomes; postoperative
Fig. 3 Weightbearing ankle radiographs showing the radiographic parameters used to measure alignment in ankles with varus ankle osteoarthritis.
a Anteroposterior view showing measurement of the tibial-ankle surface angle (TAS) and the talar tilt (TT). b Lateral view showing measurement of the
tibial-lateral surface angle (TLS)
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TAS, TT, and TLS angles as radiological outcomes; and
ICRS grade at second-look arthroscopy. For the evaluation
of the magnitudes of the differences in the outcome scores
and whether these were likely to be clinically significant,
we used a distribution based method to calculate the min-
imal clinically importance difference (MCID). According
to the distribution-based method measuring the variability
of the standard error of measurement (SEM), we com-
pared the change in clinical outcomes (VAS and AOFAS
score). The SEM is the variation in scores due to unreli-
ability of the scale or measure used. Therefore, a change
smaller than the SEM is likely to be the result of measure-
ment error rather than a true observed change. Patients
achieving a difference in outcome score of at least one
SEM would have achieved a MCID (Copay et al. 2007).
The Wilcoxon signed-rank test was used to evaluate dif-
ferences between preoperative and final follow-up values,
while the Mann–Whitney U-test was used to compare
results between groups. The χ2 test or Fisher’s exact
test was used to compare categorical data where appro-
priate. The Spearman rank-order correlation test was
used to determine the correlations between ICRS grades
at second-look arthroscopy and clinical outcomes at the
final follow-up. The correlations of postoperative radio-
logical outcomes with clinical outcomes at the final
follow-up and ICRS grades were also analyzed using the
Spearman rank-order correlation test. A P value of < 0.05
was considered statistically significant.
Results
General characteristics
Our final sample size was 62 patients (64 ankles; 31 men,
31 women). The general characteristics of the study popula-
tion are summarized in Table 1. There were no significant
differences between groups with respect to age, sex, body
mass index, or follow-up period.
Isolation and characterization of MSCs
We evaluated the capacity of human subcutaneous adipose
tissue to generate mesenchymal progenitors according to
CFU-F. Thus, after isolation, the adipose-derived stem cells
represented a mean of 8.7 % of the stromal vascular fraction
cells (range, 6.9 to 11.2 %). After the stromal vascular frac-
tions were isolated, a mean of 4.0 × 106 stem cells (8.7 % of
4.6 × 107 stromal vascular fraction cells; range, 3.2 to 5.2 ×
106 cells) were prepared. Accordingly, a mean of 4.8 × 107
stromal vascular fraction cells, which contained a mean of
4.0 × 106 stem cells, were used for MSC injection. FACS
characterization indicated positive expressions of the sur-
face markers CD90 (98.42 %) and CD105 (92.54 %), and
negative expressions of CD34 (5.78 %) and CD14 (2.46 %).
Adipose-derived stem cells treated with conditioned media
exhibited adipogenic, osteogenic, and chondrogenic differ-
entiation after staining.
Clinical and radiological outcomes
The clinical and radiological outcomes are summarized
in Table 2. The mean VAS score improved significantly
from 7.2 ± 1.0 to 4.7 ± 1.4 in group I and from 7.3 ± 0.8
to 3.7 ± 1.5 in group II at the final follow-up (P < 0.001
for both groups). The mean AOFAS score also improved
significantly from 61.7 ± 5.8 to 80.9 ± 6.7 in group I and
from 60.6 ± 6.1 to 85.2 ± 5.1 in group II at the final
follow-up (P < 0.001 for both groups). There were signifi-
cant differences in the mean VAS and AOFAS scores be-
tween groups at the final follow-up (P = 0.002 and 0.010,
respectively).
The mean preoperative TAS, TT, and TLS angles were
did not differ significantly between groups; all improved
significantly at the final follow-up (all P < 0.001). However,
there were no significant differences between groups at
the final follow-up (all n.s.).
Table 2 Clinical and radiological outcomes in both groups
Group I Group II P Value
VAS
Preoperative 7.2 ± 1.1 7.2 ± 0.8 n.s.
Final follow-up 4.9 ± 1.3 3.7 ± 1.5 .002
AOFAS score
Preoperative 62.3 ± 6.1 61.0 ± 5.8 n.s.
Final follow-up 81.2 ± 6.2 85.2 ± 5.2 .010
TAS, °
Preoperative 82.3 ± 2.2 83.0 ± 2.1 n.s.
Final follow-up 89.1 ± 2.1 89.4 ± 1.8 n.s.
TT, °
Preoperative 5.3 ± 1.1 5.6 ± 1.4 n.s.
Final follow-up 2.4 ± 0.9 2.8 ± 1.1 n.s.
TLS, °
Preoperative 77.6 ± 1.7 76.9 ± 1.8 n.s.
Final follow-up 79.3 ± 1.4 78.8 ± 1.8 n.s.
Values are expressed as mean ± standard deviation. VAS visual analog scale,
AOFAS American Orthopaedic Foot and Ankle Society ankle-hind foot scale,
TAS tibial-ankle surface angle, TT talar tilt, TLS tibial-lateral surface angle
Table 1 Comparison of the baseline demographics in both
groups
Group I Group II P Value
Ankles/patients, n 33/31 31/31
Age, y 51.4 ± 8.5 52.2 ± 5.9 n.s.
Sex, male/female, n 14/17 15/16 n.s.
Body mass index, kg/m2 26.8 ± 3.3 27.1 ± 3.2 n.s.
Side of involvement, right/left, n 15/18 17/14 n.s.
Follow-up, mo 26.6 ± 4.0 27.6 ± 5.0 n.s.
Values are expressed as mean ± standard deviation unless otherwise indicated
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Second-look arthroscopic findings
At the second-look arthroscopy, the following additional
arthroscopic procedures were performed: debridement,
synovectomy, and adhesiolysis were performed in 58 (29
in group I and 27 in group II), 37 (19 in group I and 18
in group II), and 32 (17 in group I and 16 in group II)
ankles, respectively, with no significant differences in
distribution.
The ICRS overall repair grades in each group are sum-
marized in Table 3. According to the ICRS overall repair
grades, 6.1 % and 38.7 % of lesions in groups I and II, re-
spectively, were grade I or II on the medial aspect of the
talar dome. Similarly, regarding the medial aspect of the
tibial plafond, 6.1 % and 35.5 % of lesions in groups I
and II, respectively, were grade I or II. Regarding the ar-
ticular surface of the medial malleolus, grade I or II le-
sions were observed only in group II (11.9 %). The
overall ICRS grades were better in group II than in
group I (Fig. 2); there were significant differences in
ICRS grades between groups regarding the medial aspect
of the talar dome (P = 0.015), medial aspect of the tibial
plafond (P = 0.044), and articular surface of the medial
malleolus (P = 0.005).
Correlations among clinical and radiological outcomes
and ICRS grades
ICRS grades at second-look arthroscopy were significantly
correlated with clinical outcomes at the time of second-
look arthrosocpy in both groups (all P < 0.05) (Table 4). In
other words, as the quality of repaired cartilage increased,
the VAS and AOFAS scores increased significantly in both
groups. However, there were no correlations of postopera-
tive radiological outcomes with clinical outcomes at the
final follow-up or ICRS grades at the time of second-look
arthroscopy (Table 5).
Discussion
The main finding of this study is that the clinical and
second-look arthroscopic outcomes in group II were bet-
ter compared to those in group I. Although the clinical
and radiological outcomes were similarly improved in
both groups, cartilage regeneration according to ICRS
grades, which was significantly correlated with clinical
outcomes (Table 4), was significantly better in those who
received MSC injection (Table 3). In addition, postoperative
radiological outcomes were not significantly correlated with
clinical outcomes or ICRS grades (Table 5). Therefore, the
better clinical outcomes in those who received MSC injec-
tion with marrow stimulation than those who received
marrow stimulation alone may be attributable to better car-
tilage regeneration; this finding supports our hypothesis
that additional MSC injection is helpful for cartilage re-
generation in patients with varus ankle osteoarthritis
who have undergone arthroscopic marrow stimulation
along with SMO.
In this study, we assessed the clinical outcomes in
both groups and found that VAS and AOFAS scores im-
proved significantly in group II compared with group I
at the final follow-up (P = 0.002 and 0.010, respectively)
(Table 2). In addition, the SEM in differences between the
Table 3 ICRS repair grades at second-look arthroscopy according to the location of cartilage lesion in both groups
Medial talar dome Medial tibial plafond Articular surface of MM
Group I Group II P Group I Group II P Group I Group II P
Grade .015 .044 .005
I 0 1 (3.2) 0 1 (3.2) 0 1 (3.2)
II 2 (6.1) 11 (35.5) 2 (6.1) 10 (32.3) 0 3 (9.7)
III 18 (54.5) 11 (35.5) 20 (60.6) 12 (38.7) 17 (51.5) 21 (67.7)
IV 13 (39.4) 8 (25.8) 11 (33.3) 8 (25.8) 16 (48.5) 6 (19.4)
Values are expressed as number (%). MM medial malleolus, ICRS International Cartilage Repair Society
Table 4 Correlations between ICRS repair grades at second-look arthroscopy and clinical outcomes at the time of second-look
arthroscopy in both groups
VAS AOFAS
Group I Group II Group I Group II
S rho P S rho P S rho P S rho P
ICRS grade
Medial talar dome 0.398 .022 0.568 .001 −0.602 <.001 −0.729 <.001
Medial tibial plafond 0.363 .038 0.532 .002 −0.604 <.001 −0.796 <.001
Articular surface of MM 0.395 .023 0.371 .040 −0.550 .004 −0.585 .001
Values expressed were obtained using the Spearman’s rank-order correlation test. ICRS International Cartilage Repair Society, VAS visual analog scale, AOFAS American
Orthopaedic Foot and Ankle Society ankle-hind foot scale, S rho Spearman rho, MM medial malleolus
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groups was larger than the SEM of each group. Therefore,
we considered that the differences in clinical outcomes at
final follow-up between the groups, although they were
small differences, were truly significant differences.
From the review of literatures, some authors reported
the occurrence of partial remodeling of the articular cartil-
age with cartilage regeneration after high tibial osteotomy
(Fujisawa et al. 1979; Koshino and Tsuchiya 1979). Further-
more, marrow stimulation procedures combined with high
tibial osteotomy have been attempted in order to improve
cartilage lesion remodeling (Matsunaga et al. 2007; Sterett
and Steadman 2004). Several authors reported a positive
correlation between cartilage regeneration and the clinical
outcomes of high tibial osteotomy (Koh et al. 2014;
Koshino et al. 2003; Matsui et al. 1979; Parker et al. 2011).
Accordingly, we anticipated that marrow stimulation can
improve the outcomes of SMO to a similar extent as high
tibial osteotomy. Kim et al. (Kim et al. 2014b) found a sig-
nificant correlation between cartilage regeneration and the
clinical outcomes of SMO in patients with varus ankle
osteoarthritis and reported that the arthroscopic marrow
stimulation procedure improves cartilage regeneration after
SMO. Moreover, Koh et al. (Koh et al. 2014) recently com-
pared the clinical and second-look arthroscopic outcomes
of patients undergoing high tibial osteotomy for varus
osteoarthritic knee with or without MSC injection and re-
ported better cartilage regeneration with good clinical out-
comes in patients with MSC injection than patients
without MSC injection. Taking these findings into account,
we performed MSC injection to augment marrow stimula-
tion in order to improve the outcomes of SMO for varus
ankle osteoarthritis.
Marrow stimulation procedures promote cartilage repair
by stimulating bone marrow through the subchondral
bone and by producing blood clots containing MSCs on
the articular surface (Madry et al. 2010). However, several
studies demonstrated that the cartilage regenerated by
marrow stimulation mainly has a fibrocartilaginous nature,
which is biomechanically insufficient compared to native
hyaline cartilage (Breinan et al. 2000; Convery et al. 1972;
Kaul et al. 2012; Shapiro et al. 1993). As cartilage primarily
serves a biomechanical function, tissue engineering strat-
egies must ultimately produce constructs able to exhibit
the most essential mechanical properties of native cartilage
(Diekman and Guilak 2013). Therefore, we posited that
augmenting marrow stimulation would improve cartilage
regeneration and accordingly performed supplementary
MSC injection in this study.
MSCs have recently been applied as a valuable adjunct to
marrow stimulation for cartilage regeneration. McIlwraith
et al. (McIlwraith et al. 2011) injected MSCs into microfrac-
tured chondral defects in equine models and reported that
MSCs enhanced cartilage repair quality with increased
aggrecan content and tissue firmness. Fortier et al. (Fortier
et al. 2010) compared the results of cartilage repair in
equine models treated with MSCs and microfracture with
microfracture alone; they also found MSCs could result in
the healing of acute full-thickness cartilage defects to a
greater extent than that after microfracture alone. Kim et
al. (Kim et al. 2014a; Kim et al. 2013) reported that MSC in-
jection with marrow stimulation resulted in superior clin-
ical outcomes in patients with osteochondral lesion of the
talus compared to marrow stimulation alone. Although the
present study evaluated joints with osteoarthritis, which are
characterized by diffuse degeneration of the articular cartil-
age and accompanied by subchondral bone sclerosis and
synovial inflammation (Gharbi et al. 2011) and also differ
from joints with localized chondral defects, a similar mech-
anism associated with attempted repair processes might be
mediated at least in part of the microenvironment by MSC
injection. We evaluated cartilage lesions after marrow
stimulation with SMO by second-look arthroscopy; the re-
sults show the ICRS overall repair grades were significantly
better in patients who received MSC injection with marrow
stimulation than those who received marrow stimulation
alone (Table 3). In addition, ICRS grades at second-look
arthroscopy were significantly correlated with clinical out-
comes at the final follow-up (Table 4). Furthermore, the
clinical outcomes of patients who received MSC injection
with marrow stimulation were significantly better than
those who received marrow stimulation alone (Table 2).
These results suggested that MSC injection contributed to
improved cartilage regeneration, which resulted in better
clinical outcomes.
The present study has some limitations. First, the
number of patients was relatively small, the follow-up
period was short, and the data were collected retrospect-
ively. Therefore, a large randomized prospective study
with a longer follow-up period comparing marrow
stimulation with or without MSC injection is required to
Table 5 Correlations between postoperative radiological
outcomes and clinical outcomes at final follow-up and ICRS
grades at second-look arthroscopy
TAS TT TLS
S rho P S rho P S rho P
VAS 0.112 n.s. −0.201 n.s. 0.276 n.s.
AOFAS score −0.197 n.s. 0.161 n.s. −0.237 n.s.
ICRS grade
Medial talar dome 0.062 n.s. −0.187 n.s. 0.218 n.s.
Medial tibial plafond 0.174 n.s. −0.247 n.s. 0.146 n.s.
Articular surface of MM 0.080 n.s. −0.123 n.s. 0.118 n.s.
Values expressed were obtained using the Spearman’s rank-order correlation
test. ICRS International Cartilage Repair Society, TAS tibial-ankle surface angle,
TT talar tilt, TLS tibial-lateral surface angle, S rho Spearman rho, VAS visual analog
scale, AOFAS American Orthopaedic Foot and Ankle Society ankle-hind foot scale,
MM medial malleolus
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more accurately evaluate the effect of MSCs. In addition,
because the decision whether to receive MSC injection
at the time of surgery was solely up to the patients, there
might be the problem of selection bias in this study.
From this point of view, we compared the baseline
demographics between patients who did not receive the
second-look arthroscopy and patients who underwent
the second-look arthroscopy, and found no significant
differences in basic characteristics between the patients
groups regarding patient age, sex, body mass index, side
of involvement, follow-up period, VAS score for pain,
and AOFAS score. Therefore, given that no similar stud-
ies of this size have been published, we believe that these
data are valuable for comparing the outcomes between
MSC injection with marrow stimulation and marrow
stimulation alone in patients with varus ankle osteoarth-
ritis who have undergone SMO.
First, the number of patients was relatively small, the
follow-up period was short, and the data were collected
retrospectively. Therefore, a large randomized prospective
study with a longer follow-up period comparing marrow
stimulation with or without MSC injection is required to
more accurately evaluate the effect of MSCs. In addition,
because the decision whether to receive MSC injection at
the time of surgery was solely up to the patients, there
might be the problem of selection bias in this study.
Second, we used VAS and AOFAS scores to evaluate
clinical outcomes and ICRS grades to investigate the
second-look arthroscopic outcomes after MSC injec-
tion with marrow stimulation combined with SMO. It
is important to examine the mechanical properties and
biological functions of regenerative cartilage and compare
them with those of native cartilage. Therefore, further
studies involving histologic evaluation in conjunction with
clinical and arthroscopic outcomes and power analysis are
required to clarify the effect of MSC injection. Third, the
second-look arthroscopy was performed 1 year postopera-
tively. It is unknown how the repaired cartilage will behave
over the long term, and changes in the influential factors
after the first postoperative year cannot be predicted at
present. Furthermore, the ICRS grades at second-look
arthroscopic surgery were assessed by the surgeon. There-
fore, to avoid potential bias, assessment of the ICRS grade
by an independent observer who is blinded to the surgical
technique is required for a more objective evaluation.
In addition, a power analysis with inter-observer vari-
ability in the articular cartilage grading system would
be useful in future studies. We added these sentences
in the limitation section. Fourth, the loss of correction
after SMO could influence the clinical outcome. Although
there was no significant correlation of postoperative
radiological outcomes with clinical outcomes at the
final follow-up and ICRS grade (Table 5), the long-term
radiological outcomes might influence the clinical
outcomes. Finally, the optimal number of MSCs to be ap-
plied remains unknown.
Conclusions
The clinical and second-look arthroscopic outcomes of
MSC injection with marrow stimulation were better com-
pared to those of marrow stimulation alone in patients with
varus ankle osteoarthritis who have undergone SMO. Fur-
thermore, the ICRS grade is significantly correlated with
clinical outcome.
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